Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fine Chemicals. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101891571A details a Pd-catalyzed carbonylation route for unsaturated ketones. Offers high purity intermediates and streamlined supply chain solutions.
Patent CN110055297B details a novel esterase for resolving (R,S)-5-caprolactone with >98% ee. Discover cost-effective biocatalytic routes for high-purity flavor intermediates.
Patent CN114605458A details a novel Rh-catalyzed C-C bond activation method for high-purity chiral intermediates, offering significant cost reduction in API manufacturing.
Novel silver catalyzed synthesis offers high yield and cost efficiency for pharmaceutical intermediates. Scalable process ensures reliable supply chain continuity for global buyers.
Patent CN116143673A reveals a novel Ni-Cu oxide catalyzed route for diphenyl sulfide, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN117756644A reveals a novel method converting caprolactam by-products into high-purity N-hexylcyclohexylamine, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN116283515A reveals a direct cross-coupling method using aryl fluorides and bromides. This technology offers significant cost reduction and simplified supply chains for pharmaceutical intermediates.
Novel carbonyl insertion method using N-formyl saccharin avoids toxic CO gas, offering safe, scalable production of alkynone intermediates.
Patent CN113200932B reveals a novel TDAC-catalyzed route for oxazolidinone synthesis, offering metal-free purity and chiral retention for pharmaceutical intermediates.
Patent CN102675168A details a high-ee iridium-catalyzed allylation method for chiral thioethers, offering superior regioselectivity and mild conditions for API intermediates.
Novel one-step nickel catalysis replaces toxic cyanogen bromide. High yield, mild conditions for reliable pharmaceutical intermediate manufacturing.
Patent CN1882600A reveals a novel route for enantiomerically enriched bisphospholane ligands, offering significant cost reduction in pharmaceutical intermediate manufacturing and improved supply chain reliability.
Patent CN102030658B reveals a safer route to 3-cyclopentamine using nitromethane cyclization, offering cost reduction and supply chain stability for pharmaceutical intermediates.
Patent CN107266283B introduces a novel diacyl peroxide method for Heck reactions. Achieve high-purity pharmaceutical intermediates with reduced costs and scalable supply chains.
Patent CN117003647A details a Ru-Co alloy catalyst for low-temperature reductive amination, offering high yield and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN101993398B details a green catalytic hydrogenation method for 1,8-diamino-3,6-naphthalene disulfonic acid, offering high purity and eliminating iron sludge waste for reliable supply.
Patent CN110845534A details a novel oxidative coupling method for phosphoramide compounds, offering high stereoselectivity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN111270260A introduces a green electrochemical Rh-catalyzed alkenylation method, offering cost reduction and scalable solutions for fine chemical manufacturing.
Patent CN111995525A reveals a mild hydrogenation method using nanoporous PtFe catalyst, offering high selectivity and cost reduction in pharmaceutical intermediate manufacturing.
Discover the novel radical tandem reaction for beta,delta-substituted aromatic ketones. This patent offers cost reduction in fine chemical manufacturing with high purity.